Descuento:
-5%Antes:
Despues:
138,31 €· Focuses on the rare lymphomas often not covered in other books
· Provides a comprehensive overview of current treatment strategies
· Emphasizes translation of molecular science into clinical care
· Most chapters authored by pairs of American and European experts, representing worldwide standards
The past decade has witnessed tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma as well as in understanding of the underlying molecular pathogenesis. Optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors. Even more importantly, molecular targeted approaches have been shown to be effective in the treatment of distinct lymphoma subtypes. Against this background, clinical management of especially the rare lymphomas remains a challenge for the general oncologist.
This book provides a comprehensive overview of current treatment strategies in these rare lymphoma subtypes. Experts in the field from around the world describe the histomorphology in a clinically relevant manner, consider the role of risk factors in detail, and discuss the spectrum of therapeutic approaches. Special emphasis is placed on the translation of molecular science into clinical care, and a disease-specific algorithm is proposed for each entity. This book will prove an excellent resource for both experienced and inexperienced practitioners.
Content Level » Professional/practitioner
Keywords » Malignant Lymphoma - Molecular Pathogenesis - Targeted Approaches
Related subjects » Internal Medicine - Oncology & Hematology
Table of contents (19 chapters)
1.Principles of the Pathology and Biology of Malignant Lymphomas
2.Cytogenetics
3.Molecular Genetics of Rare Lymphomas
4.Signaling Pathways in Rare Lymphomas
5.Adult T-cell Leukemia-Lymphoma
6.Anaplastic Large Cell Lymphoma
7.Extranodal NK/T-Cell Lymphoma, Nasal Type
8.Cutaneous T-Cell Lymphoma
9.Adult Burkitt Lymphoma and Leukemia
10.Primary Mediastinal Large B-Cell Lymphoma
11.CNS Lymphoma
12.HIV-Associated Lymphomas
13.Non-MALT Marginal Zone Lymphoma
14.Mucosal-Associated Lymphoid Tissue (MALT) Lymphoma
15.Mantle Cell Lymphoma
16.Waldenström’s Macroglobulinemia
17.B-Cell Prolymphocytic Leukemia (B-PLL) and T-Cell Prolymphocytic Leukemia (T-PLL)
18.Nodular Lymphocyte-Predominant Hodgkin Lymphoma
19.Primary Cutaneous B-Cell Lymphomas
-5%
-5%
-5%
-5%
-5%
-5%
-5%
-5%
-5%
-5%
